8th Annual Meeting of the Oligonucleotide Therapeutics Society

Join in October 28-31 in Boston, Massachusetts for the

8th Annual Meeting of the Oligonucleotide Therapeutics Society!

Join leading experts in the field during this three day meeting, which will feature the latest developments from various oligonucleotide-based disciplines including antisense, siRNA, immunomodulatory, aptamers and micro/non-coding RNA research.

Organizing Chair

Muthiah Manoharan, PhD, Alnylam Pharmaceuticals

Scientific Program Committee

Masad Damha, PhD, McGill University
Fritz Eckstein, PhD, Max Planck Institute
Anastasia Khvorova, PhD, RXi Pharma
Ryszard Kole, PhD, AVI BioPharma
Art Krieg, MD, Atlas Venture
Art Levin, PhD, Santaris Pharma A/S
Akira Matsuda, PhD, Hokkaido University
Tom Tuschl, PhD, Rockefeller University

Keynote Session

Keynote Speaker
Phillip A. Sharp, PhD, Massachusetts Institute of Technology
Plenary Speakers
John Maraganore, PhD, Alnylam Pharmaceuticals
Stanley T. Crooke, MD, PhD, Isis Pharmaceuticals

Topics will include all areas of Oligonucleotide Therapeutics covering:

• Imparting Drug-like Properties via Chemical Modifications
• Structural Biology of Therapeutic Mechanisms
• Emerging Delivery Technologies and their ADME Properties
• Novel Therapeutic Targets and Bioinformatic Tools
• Novel Mechanisms and Technologies
• Clinical Development

 

for information: click here